Table 3 Comparison of number and proportion of differentially methylated CpGs in various categories of CpGs.
# of positives in EWASplus predicted positives (%) total = 38 | # of positive in on-array positives (%) total = 10 | # of positives in EWASplus predicted negatives (%) total = 10 | |
|---|---|---|---|
Any trait | 25 (65.8) | 6 (60.0) | 3 (10.0) |
Beta-amyloid | 17 (44.7) | 1 (10.0) | 2 (20.0) |
Braak staging | 11 (28.9) | 2 (20.0) | 1 (10.0) |
CERAD | 17 (44.7) | 2 (20.0) | 3 (30.0) |
Cognitive trajectory | 7 (18.4) | 3 (30.0) | 0 (0.0) |
Global pathology | 13 (34.2) | 2 (20.0) | 3 (30.0) |
Neurofibrillary tangles | 16 (42.1) | 5 (50.0) | 1 (10.0) |
